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DOI: 10.1039/c0nr00237bAs interest in using carbon nanotubes for developing biologically compatible systems continues to
grow, biological inspiration is stimulating new directions for in vivo approaches. The ability to integrate
nanotechnology-based systems in the body will provide greater successes if the implanted material is
made to mimic elements of the biological milieu especially through tuning physical and chemical
characteristics. Here, we demonstrate the highly successful capacity for in vivo implantation of a new
carbon nanotube-based composite that is, itself, integrated with a hydroxyapatite-polymethyl
methacrylate to create a nanocomposite. The success of this approach is grounded in finely tailoring the
physical and chemical properties of this composite for the critical demands of biological integration.
This is accomplished through controlling the surface modification scheme, which affects the
interactions between carbon nanotubes and the hydroxyapatite-polymethyl methacrylate.
Furthermore, we carefully examine cellular response with respect to adhesion and proliferation to
examine in vitro compatibility capacity. Our results indicate that this new composite accelerates cell
maturation through providing a mechanically competent bone matrix; this likely facilitates
osteointegration in vivo. We believe that these results will have applications in a diversity of areas
including carbon nanotube, regeneration, chemistry, and engineering research.Introduction
Carbon nanotubes (CNTs), with their unique and fascinating
one-dimensional nanostructure, are becoming increasingly
important for their use in novel development directions for
groundbreaking biomedical applications. Of significant biologi-
cal importance when utilizing this technology is to exercise
control over mechanical properties at the material–biological
interface.1 Manipulation of mechanical properties within these
systems can dictate cell response and affect many physiological
responses.2,3 CNTs have already been employed in the mechanics
of materials domain for decades because of their high strength,
which makes them ideal for a variety of applications including
polymeric composite systems. Their successes in vivo though have
been inhibited by physiological challenges as the promise of
introducing pristine nonfunctionalized CNTs in polymer
matrixes has been limited because this type of nanomaterial is
practically insoluble and can accumulate in cells, organs, and
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This journal is ª The Royal Society of Chemistry 2010overcome, however, by chemically modifying the surfaces of the
CNTs, which addresses the solubility challenges in most solvents
and polymers.6–8
Modifying the surface properties can introduce trade-offs
between the design ability and the implantation success. From
a mechanics perspective the atomically smooth surface of
nanotubes that reduces interfacial bonding creates a challenge, as
the load transfer is then limited between the matrix and the
CNTs. This surface and mechanics related issue is a result of
intrinsic Van der Waals forces, which is further complicated by
the fact that nanotubes have very low solubility in most solvents
and are typically found in bundles. When mixed into a polymeric
matrix, CNTs tend to be entangled agglomerates, and homo-
geneous dispersions are not easily obtained which directly affects
the mechanical properties. In previous work we have facilitated
CNT dispersion while reducing the aggregation by integrating
carboxylic functionalized CNTs in a polymethyl methacrylate
(PMMA) matrix through a freeze granulation technique,9 which
indicates that the surface interactions are important and can be
controlled. The interfacial interaction between CNTs and poly-
mers and the ability to disperse them homogeneously throughout
a matrix are critical factors toward fully utilising the extraordi-
nary properties of CNTs.
For developing a biologically inspired composite system, there
are numerous available composite materials. One particular area
that has shown promise is in using bone cements such as PMMA.
PMMA has been extensively used in orthopaedic surgery as
a biomaterial that fixes artificial joints to bone and fills bone
defects, as well as a drug-delivery system.10 One well documented
issue with bone cements is that the fixation strength of
PMMA cement to bone is primarily dependent on mechanicalNanoscale, 2010, 2, 2855–2863 | 2855
characteristics. To address this, a complementary material,
hydroxyapatite (HA), has been used with PMMA. HA is a prime
constituent of bone cements and is particularly useful for a range
of reasons including its ability to bond chemically with living
bone tissues as well as its chemical and crystalline similarity to
human skeletal apatite. These systems alone though exhibit
intrinsic brittleness and poor strength, thus restricting its clinical
applications under load-bearing conditions.11–14 The ability to
develop CNT composites holds great promise for producing
high-strength biomaterials, in particular those to be positioned in
close contact with bones, such as prostheses for arthroplasty,
plates or screws for fracture fixation, drug delivery systems, and
scaffolding for bone regeneration.15,16 Providing enhanced
mechanical properties is critical for these approaches to be
successful as failure of material systems leads directly to delete-
rious consequences. Although this is an advantageous property,
controlling the mechanical properties is not a simple task due to
mixing and surface interaction issues.
Our approach is based on inspiration from the biological
domain where controlling both physical and chemical interac-
tions are critical for producing a highly compatible system. We
believe that there are at least two key integrated components that
need to be achieved: (i) the composite biomaterial must mimicFig. 1 Schematic diagram for the synthesis and biological testing of a chemica
step approach is used to generate this nanocomposite. In the first step, a homo
In the second step, this solution was mixed with 0.1 wt % of functionalize
Through this technique, the material homogeneity was preserved and the dispe
the in vivo and in vitro studies, a mixture of the monomer solution of the bioact
nanocomposite was prepared. (b) A SEM image of 0.1% COOH-MWCNT/PM
the HA-PMMA-0.1% COOH-MWCNT nanocomposite. (d) Digital image o
cement paste in three holes of a sheep tibia.
2856 | Nanoscale, 2010, 2, 2855–2863the mechanical behaviour of the tissue to be replaced, and; (ii) it
must be able to form a steady interface to assist remodeling of
bone tissue. In this context, biocompatibility in bone is a very
important component given that recovering from trauma is
a complex process that involves the activation and formation of
osteoblastic cells from undifferentiated mesenchymal osteopro-
genitor cells, synthesis of a new organic matrix, and absorption
of the preexisting matrix in the injured bone. To address this, one
must accelerate the rate of bone fracture healing such that the
fixation mechanisms and materials used provide controlled
mechanical stress at the interface between tissue and the implant.
This is believed to accelerate the activity of bone cells that are key
regulating agents of bone-response to implanted materials.17
Here, we developed a new CNT-based composite integrated with
hydroxyapatite-polymethyl methacrylate (HA/PMMA) with
controlled physical and chemical properties (Fig. 1). We
implanted the composite in bone and observed significantly
improved biocompatibility. Next, the mechanical properties of
this composite were determined relative to the surface function-
alization that we imposed on the CNTs for the composite. We
then analyzed the cellular response to these composites to
understand the in vitro response, which contributed to the
successful in vivo implantation.lly modified MWCNT-reinforced PMMA/HA nanocomposite. (a) A two-
genous mixture of HA powder and PMMA was prepared by ball milling.
d MWCNTs (both with –COOH/or –NH2) through freeze-granulation.
rsion of the carbon nanotubes was enhanced in the composite matrix. For
ive bone cement and dry powder of the MWCNT-reinforced PMMA/HA
MA/HA nanocomposite paste. (c) SEM image of MG63 cells growing on
f filling the bone during the surgical procedure with the bioactive bone
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Experimental section
1. Creation of carbon nanotube composites
1.1 Dispersion of covalent or noncovalent functionalized multi-
walled carbon nanotubes (MWCNTs–COOH/or –NH2) in water.
Commercially available (purity >95%, Nanocyl-3150) MW-
CNTs with lengths of 1–5 mm and diameters of 5–10 nm
were suspended in a 3 : 1 mixture of concentrated H2SO4
(18.4 M)/HNO3(16 M) and sonicated in a water bath for 24 h.
The resulting suspension was then diluted with deionized water,
and the MWCNTs were collected on a 100 nm pore membrane
filter before being washed with deionized water. Based on the
established procedure for noncovalent functionalization of
CNTs with pyrenyl compounds,18 300 mg of these MWCNTs
were sonicated in a 200 mL ethanol solution containing 300 mg
of 1-aminopyrene (purity >99%, Sigma Aldrich) for 2 h in
nitrogen atmosphere. This mixture was stirred overnight.
Subsequently, the amino-MWCNTs were collected on a 100 nm
pore membrane filter and washed with deionized water. The
resultant covalent or noncovalent functionalized multiwalled
carbon nanotubes were analyzed using FTIR (Nicolet
AVATAR-360 FT-IR spectrophotometer) (see Fig. 3a).
1.2 Freeze-granulation technique to produce PMMA and HA
nanocomposites with well dispersed functionalized MWCNTs. The
homogenous solution of 0.1 wt % of functionalized MWCNTs
(both with –COOH/or –NH2) in water was mixed with a combi-
nation of commercially available PMMA (high viscosity bone
cement purity >99%, Johnson and Johnson Co.) and HA
(particle size 2–3 mm with purity >98%, Agoramat-Advanced
Materials) at a 1 : 2 weight percentage. This homogenous
mixture of HA powders and PMMA was prepared by ball
milling.19 There is no effect on HA powder size distribution
during ball milling as the ball milling inhibits the agglomeration
of HA powder during the mixing of PMMA with HA.
The freeze-granulation technique (Power Pro Freeze-granu-
lator L5-2, Sweden) dried the nanocomposite of functionalized
MWCNT-reinforced PMMA/HA powder, preserved the mate-
rial homogeneity, and enhanced the dispersion of the carbon
nanotubes in the composite matrix.9 Fig. 1 shows a schematic
diagram for the step-by-step procedure for creating the
MWCNT-reinforced PMMA/HA nanocomposites. Granules
with no cavities can be created, and, since no migration of small
particles was possible, a high degree of granule homogeneity can
be produced while the mild drying avoids oxidation of the
powder.20 Also, lower granule density and evenly distributed low
concentrations of MWCNTs allowed for softer granules with
a wider granule size distribution. The freeze-dried nanoparticles
were then collected and dried in vacuum for 3 days. In order to
remove any remaining liquid, the nanocomposite was placed in
an oven at 40 C for 24 h.
2. Surface characterization and mechanical properties
2.1 Experimental surface characterization
2.1.1 FE-SEM. Field-emission scanning electron micro-
scopy (Hitachi S-800, and SU-70, 30 keV) was performed to
study the dispersion and distribution of the functionalized
MWCNTs (both with –COOH/or –NH2) in the PMMA modifiedThis journal is ª The Royal Society of Chemistry 2010HA matrix. The phase composition and purity of the samples
were determined with a Philips Xpert-MPD X-ray powder
diffractometer with Co Ka radiation at 45 kV and 40 mA. Room
temperature micro-Raman studies were also performed to study
the integration of MWCNTs with the PMMA-HA nano-
composite material.
2.2 Determination of mechanical properties
2.2.1 MTS Nano Indenter XP. Nanoindentation tests were
performed using an MTS Nano Indenter XP with a Berkovich
diamond tip.21 Hardness and elastic modulus of the PMMA/HA
nanocomposite with different percentages of MWCNTs were
measured as a function of the indentation depth using a contin-
uous stiffness measurement (CSM) method. The typical nano-
indentation test consisted of seven subsequent steps: 1)
approaching the nanocomposite surface; 2) determining the
contact point; 3) loading to the peak load; 4) holding the tip for
10 s at the peak load; 5) unloading 90% of the peak load; 6)
holding the tip for 100 s at 10% of the peak load to compensate
for the thermal drift correction; and, 7) unloading the nano-
composite completely. The hardness and elastic modulus from
these experiments were obtained through the Oliver–Pharr
method.223. In vivo methods
3.1 Animal model. Following the experimental protocol
approved by the National Ethics Committee for Laboratory
Animals (Portugal),23 two healthy, adult male sheep with average
weight of 45 kg, were used for the in vivo implantation. The sheep
were permanently housed indoors in group housing and were
kept under a constant photoperiod cycle (light: from 07 : 00 to
19 : 00 h; dark: from 07 : 00 to 19 : 00 h), temperature (20 2 C)
and humidity (50  10%). Food was withdrawn 36 h, and water
6 h prior to anaesthesia.
3.2 Anaesthetic and surgical method. Surgery was performed
under general anaesthesia, which was induced with pentobarbital
through intravenous injection; the animals had been previously
premedicated with xilazine and buprenorphine. The anaesthesia
was maintained through using isoflurane administered with an
endotracheal tube and spontaneous ventilation. An electrocar-
diogram (ECG) monitor and a pulsioximeter were used to
monitor the condition of the animals. The antibiotherapy was
initiated during surgery with amoxicillin (Clamoxyl) and these
therapies were maintained for one week. The site of the surgery
was prepped with a solution of Betadine (povidone-iodine) and
alcohol (Dura-Prep; 3M Health Care, St. Paul, MN) after the
animals were locally shaved. For the implantation of the bio-
active bone cement in the tibia, the animals were placed in
a dorsal recumbency position and a longitudinal incision was
made on the frontal surface of the left and right tibia. After
exposure of the tibial bone, the periosteum was reflected and
a 2.5 mm diameter pilot hole was made with a surgical drill and
then enlarged with low speed drilling to a 3.0 mm diameter.
During the process, the bone was continuously perfused with
a sterile saline solution. Three holes were drilled on each tibia as
shown in Fig. S1 (see Supplementary Information†) and then the
holes were filled with the bioactive bone cement paste (Fig. 1d).Nanoscale, 2010, 2, 2855–2863 | 2857
The surgery field was covered with subcutaneous tissue and the
skin was closed using absorbable Surgicryl  2–0 sutures.
3.3 Radiological and histological studies. Post-operative
X-ray tests were performed with a Mammodiagnost UC system
(Philips) with 28 kV, 25 mA, using coarse focus and Kodak Min-
R Screen film. Twelve weeks after implantation, the animals were
sacrificed with an intravenous dose of sodium pentobarbital
(Eutasil). The implanted materials and the surrounding tissue
was removed. The bone specimens for the histological evaluation
were fixed in 4% buffered formaldehyde, dehydrated in graded
alcohols and embedded in methyl methacrylate (Merck Supplier
Part: 8.00590.1000). After polymerization, non-decalcified 30 mm
sections were obtained in the transversal direction using a saw
microtome (Leica 1600) and then ground with silicon carbide
powder. Thin sections were prepared of each specimen for
evaluation by light microscopy (Eclipse 600, Nikon Japan). The
bone sections were stained with toluidine blue.24,254. In vitro methods
4.1 Cell culture. The MG63 cell line, derived from human
bone osteosarcoma, was used for direct contact assays. MG63
cells were grown in Alpha Minimum Essential Medium
(a-MEM, Gibco) containing 10% fetal bovine serum (FBS),
2.5 mg mL1 fungizone, 100 U mL1 penicillin-streptomycin and
85 mg mL1 gentamicin.26 During routine propagation, the cells
were maintained in 75 cm2 Nunc Easy Flasks at 37 C in
humidified atmosphere containing 5% CO2 for 3–4 days. Then,
the cells were removed by applying a trypsin–EDTA solution
and seeded on the disk shaped composite samples at 1.5 
105 cells mL1 in 12-well polystyrene culture plates, using the
same culture conditions. In the control cultures, the cells were
cultured in 12-well polystyrene culture plates at the same density
as on the samples. Media were changed either every 2–3 days or
24 h prior to analysis.
4.2 Cell viability/growth/morphology assays. The determina-
tion of cell growth and viability of cell cultures was performed by
analyzing cell cultures after staining with trypan blue (vital dye
exclusion method) and by measuring the activity of living cells via
mitochondrial dehydrogenase activity (3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyl tetrazolium bromide, MTT, based spectropho-
tometric method). The viability analyzer, Vi-CELL XR,
Beckman Coulter, was used for the trypan blue dye exclusion
method in cell suspensions obtained after trypsinization. Fifty
real time images were collected per sample and the number of
living and dead cells was recorded per frame to calculate the cell
concentration and viability. These images also were used to
construct distribution plots of average cell diameter and circu-
larity (
ffiffiffiffiffiffiffiffiffiffiffiffiffi
4A
.
p
r 
P=p, where A and P represent the pixel cell
area and perimeter, respectively). The ‘‘Cell growth determina-
tion kit MTT-based’’ from SIGMA was employed to assess cell
viability directly in the 12-well polystyrene plates. Both methods
were conducted according the manufacturer instructions.
4.3 Alkaline phosphatase (ALP) activity. The treatment of
cell cultures to quantify the activity of alkaline phosphatase,2858 | Nanoscale, 2010, 2, 2855–2863a typical representation of osteogenic activity of osteoblasts27,28
was similar to that described previously.29,30 Briefly, the medium
of each well was collected to analyze secreted ALP, whereas
cellular ALP was quantified after a 5 min lysis of the cell cultures,
which were rinsed once with phosphate buffered saline (PBS),
using 0.1% Triton X-100 (v/v) in 25 mM Na2CO3 (pH 10.3).
Lysates remained in the culture conditions in reaction medium
for 2 h and then the reactions were stopped by adding 2 M
NaOH. Both secreted and cellular ALP activities were measured
spectrophotometrically, using 15 mM p-nitrophenol phosphate
(pNPP) as the substrate in alkaline reaction medium (pH 10.3)
containing 2.5 mM MgCl2, at 37
C. The enzyme activity was
determined by measuring the increase in absorbance at 410 nm
accompanying the production of p-nitrophenol with a molar
absorption coefficient of 1.73  104 M1cm1 and normalized
by the number of cells.
4.4 Data analysis. Statistical analysis was performed using
Student’s t-test. Data are reported as mean  standard error
(S.E.) and P values <0.05 were considered to be significant.Results and discussion
The first critical step in developing this approach was to analyze
the response of the CNT-reinforced HA/PMMA nano-
composites. These nanocomposites were derived via a two-step
process (Fig. 1a). In the first step, a homogenous mixture of HA
powder and PMMA was prepared by ball milling. The second
step consisted of mixing this combination with a homogenous
solution of 0.1 wt % of functionalized MWCNTs (both with
–COOH/or –NH2). The MWCNT solution was introduced into
water using a freeze-granulation technique, which allowed us to
preserve the material homogeneity and enhance the dispersion of
the CNTs in the composite matrix (Fig. 1b). After creating these
nanocomposites, determining their in vitro and in vivo (Fig. 1c
and 1d) response was essential.31
To examine the in vivo response with the nanocomposites,
X-ray tests were performed. After twelve weeks the inflammatory
reactions in the surrounding tissues were examined. X-rays of the
left tibia were captured immediately after surgery (Fig. 2i) and
then after 12 weeks (Fig. 2ii). The drilled cavities, as indicated by
an asterisk in Fig. 2(i) and (ii), had been invaded by the marrow
region. Also, there were no signs of periosteal or bone negative
reactions twelve weeks after implantation. Fig. 2(iii–vi) provided
a histological evaluation of the stained specimens obtained
twelve weeks after implantation. The periosteum covering the
outer surface of the implant and the cortical bone at the interface
did not show any adverse reaction to the implants (Fig. 2iii,iv).
Furthermore, the contact between the cement and the bone
showed no fibrous tissues or inflammatory cells as observed in
Fig. 2iii. Osteocytes (denoted by red dotted circle in Fig. 2iii)
were clearly observed. At higher magnifications, a favourable
interface between bone and the cement was observed (Fig. 2iv).
However, in the areas where there was no direct contact between
the bone and the implant, osteoclast-like cells32 appeared on the
cement surface (indicated by the green dotted circle in Fig. 2v).
Furthermore, in our specimens (Fig. 2vi), new bone (B) clearly
penetrated the pores of the bone cement (C), as indicated by the
green dotted arrow. The biocompatibility and osteoconductivityThis journal is ª The Royal Society of Chemistry 2010
Fig. 2 In vivo response with the nanocomposite bone cement in sheep. (i)
X-rays (left tibia) immediately after surgery and (ii) after 12 weeks.
Invasion of the marrow region (indicated by the asterisk) and restoration
of the cavities is observed. There are no inflammatory reactions in the
surrounding tissues after 12 weeks. (iii) An image of Giemsa surface
staining of the specimens at 12 weeks after implantation shows excellent
contact between the nanocomposite PMMA-HA-CNT bioactive-bone
cement (C) and the bone tissue (B) with no fibrous tissues and no
inflammatory cell infiltration. Oteocytes, which are indicated by the red
dotted circle regions, are observed. (iv) An image of Giemsa surface
staining focusing on the interface between the nanocomposite bioactive
bone cement and the tissue (C) and the bone tissue (B), which is very
favourable. (v) An image of Giemsa surface staining focusing revealing
multinuclear osteoclast-like cells covering the surface of the bone cement,
as indicated by the green dotted circles; there was no direct contact
between bioactive-bone cement (C) and bone tissue (B) generally
observed. (vi) An image of Giemsa surface staining focusing showing that
the new bone (B) clearly enters into the pores of the bone cement (C), as
indicated by the green dotted arrow.
Fig. 3 Surface characterization and mechanical properties of the
nanocomposite bone cement. (a) FTIR spectra for carboxylated (red),
amine (black), and pristine (green) MWCNTs. The band at 1729 cm1 is
attributed to the carboxylated group as MWCNTs are functionalized
with the –COOH group. Similarly, peaks at 1640 cm1 and 3421 cm1
correspond to NH2. These functional groups are absent though for
unmodified MWCNTs. SEM images of (b) carboxylated, (c) amine, and
(d) non-functionalized MWCNT-reinforced PMMA/HA nano-
composites. (e) Representative load–displacement curves at a peak
indentation load of 10 mN for the PMMA-HA with 0.1% carboxylated
(red), amine (blue) and non-functionalized (green) MWCNTs.are critical factors as foreign material reside in vivo. A post-
mortem examination of the tibias revealed that the implants were
completely covered by the periosteum. This finding was deter-
mined by fixing the regional lymph nodes with 4% formaldehyde,
embedding them in paraphin, and then cutting them into 30 mm
sections with a microtome (Leica, Jung RM 2045). The speci-
mens were stained with hematoxylin/eosin to examine the
biocompatibility and osteoconductivity responses. The histo-
logical response of the regional lymph nodes revealed no
significant morphologic changes in the regional lymph nodes
between the control and test groups. The histological evaluations
demonstrate that the CNT-reinforced composite with the
bioactive bone cement responded favourably as a tibial bone
implant based on its osteoconductivity and biocompatibilityThis journal is ª The Royal Society of Chemistry 2010results. This biocompatibility has been demonstrated for an
extended time period of 12 week post-operation for our 0.1%
MWCNT-PMMA/HAp nanocomposites.
Examining the mechanical properties of these nanocomposites
was also essential for in vivo successes in implantation since
mimicking mechanical properties in materials is essential to
biological response.1 While surface functionalization has gained
much attention recently with respect to biocompatibility issues,
the functionalization can also influence mechanical properties of
these composites.9,33 Previously, the surfaces have been modi-
fied34,35 although even with these approaches, delamination
under fatigue has occurred until CNTs were integrated into the
composite.9 Even with surface modifications, such as producing
amine groups at the surface of the CNTs, increasing CNT
concentrations beyond 1% did not appear to measurably
improve the mechanical properties.36 In addition, while the
incorporation of CNTs in living systems has been the subject of
numerous studies, functionalizing CNTs has produced signifi-
cant promise toward addressing concerns. To study this link
between surface functionalization and mechanical properties, we
functionalized CNTs (Fig. 3a) and then used a nanoidentation
technique (MTS Nano Indenter XP with a Berkovich diamond
tip) to study their resulting mechanical properties when imbed-
ded in PMMA/HA nanocomposite (Fig. 3b–d). The composite
responses were probed with CNTs, without CNTs, and with
controlled surface functionalizations. In our experiment we have
modified the surface of MWCNTs with bifunctional moleculesNanoscale, 2010, 2, 2855–2863 | 2859
Fig. 4 Cell culture response to the HA/PMMA-CNTs nanocomposite.
(a) Temporal evolution of MG63 cell growth on polystyrene (:), HA-
PMMA (B) and HA-PMMA-0.1% CNTs (C). The experiments were
conducted in triplicate, with each experimental conditions evaluated from
150 images. The images were captured using a Vi-CELL XR video
imaging system for analyzing cells in suspension and the data corre-
sponds to a total number of analyzed cells of 1831 (for polystyrene), 1683
(for HA-PMMA) and 1364 (for HA-PMMA-0.1% CNTs). The inset
shows a growth curve for MG63 cells cultured in 12-well polystyrene
culture plates (total number of analyzed images and cells of 800 and
11937, respectively). Experimental data are expressed as viable cell
density (mean  S.E.). (b) A SEM image of MG63 cell growing on the
HA-PMMA-0.1% CNTs nanocomposite. (c) Cell viability of MG63 cell
cultures seeded on distinct surfaces (:, polystyrene; B, HA-PMMA;
and C, HA-PMMA-0.1%CNTs) remained very high during an 8 day(1-aminopyrene) using the well-known noncovalent interactions
between the pyrenyl groups of 1-aminopyrene and the six-
membered carbon rings of the nanotubes. On the other hand
carboxylic acid (COOH) are direct sidewall reactions (covalently
bonded with CNTs).
The hardness and elastic modulus values as a function of the
indentation depth for PMMA/HA and its 0.1% MWCNTs
reinforced samples were found through analyzing load-
displacement curves at a peak indentation load of 10 mN
(Fig. 3e). Thirty-two nanoindentation tests were conducted on
each sample to determine the average hardness and elastic
modulus for these composites (Table 1). From Table 1, the
PMMA/HA with 0.1% COOH-functionalized MWCNTs
(Fig. 3b) exhibited a significantly higher hardness (3.5 GPa) and
elastic modulus (69 GPa). The NH2-functionalized MWCNTs
had similar mechanical properties as the samples lacking func-
tionalized MWCNTs. We assume that during the composite
preparation an internal stress occurs between functional group
and carbon nanowall surface, which results in the release of some
CNTs and some agglomeration that behaves like defects in the
matrix, which was observed Fig. 3c and 3d. In addition, from
a visual examination of the SEM images, these nanocomposites
displayed a significant amount of creep strain at the peak load
and did not exhibit cracks formed during indentation. Investi-
gating the holding segment at the peak load is an important
component as the dissipation of creep displacement in most
polymeric biomaterials and tissues often exhibits similar
responses in terms of time-dependent or viscoelastic behavi-
our.37,38 This is important as bone is also a natural composite that
exhibits viscoelastic behaviour. Based on these nanoindentation
results, it appears that the mechanical properties of this PMMA/
HA nanocomposite with 0.1% COOH-functionalized MWCNTs
are compatible for use in bone applications. In this case, in the
matrix there is a direct load transfer from the PMMA/HA to the
CNTs, where COOH-functionalized CNTs behave like a perfect
reinforced material in the matrix nanocomposite. But this is not
the case with amine-modified CNTs. That is why the covalently
bonded COOH group functionalized CNTs shows best
mechanical properties compare to noncovalently amine-modi-
fied/or non-functionalized CNTs, and best suitable for load
bearing applications.
From a cellular compatibility standpoint, we probed overall
growth potential first. To accomplish this, we used immortalized
MG63 cells, which have a high proliferative potential. The
growth rate of the cell cultures under control conditions wasTable 1 Average values of hardness and elastic modulus for chemically
modified and non-functionalized 0.1% MWCNTs in the PMMA/HA
nanocomposite. The PMMA/HA with 0.1% COOH-functionalized
MWCNTs exhibited a significantly higher hardness (3.5 GPa) and elastic
modulus (69 GPa) compared to NH2-functionalized and non-
functionalized MWCNTs/PMMA/HA nanocomposites. The SEM was
0.60 GPa for the elastic modulus and 0.05 GPa for the hardness
H/GPa E/GPa
HA/PMMA/MWCNTs–COOH 3.5 69
HA/PMMA/MWCNTs–NH2 0.126 5.03
HA/PMMA/MWCNTs–non-
functionalized
0.363 7.61
2860 | Nanoscale, 2010, 2, 2855–2863calculated by counting the number of viable cells in 1200 samples
collected from 12 polystyrene wells from day 1 to day 14. Cell
cultures exhibited exponential growth with a time constant of 20
 2 h1, reaching half of maximal density (1.46  106  4.44 
104 cells mL1) in 95  3 h (r2 ¼ 0.98132) as observed in Fig. 4a
(inset). For the nanocomposites, the growth rates of cell cultures
seeded on disk-shaped HA/PMMA and HA/PMMA-CNTs
samples (Fig. 4b) decreased minimally by only 2 and 4%,
respectively (Fig. 4a). In addition, the viable cell densityincubation period. Experimental data are expressed as the percentage of
cells that have not absorbed trypan blue (light cells in the inset image)
with respect to the total number of cells in each image. As indicated by the
black arrow, cells taking up the trypan blue dye appeared darker. The
data points represent the cell viability values (mean  S.E.) for each
experimental condition, which were analyzed in at least 50 images. (d)
Alkaline phosphatase activity (ALP) of MG63 cells solubilized with
Triton X-100 (cellular ALP) and in culture medium above each material
surface (secreted ALP). Cellular (,) and secreted ALP (-) in HA-
PMMA and HA-PMMA-0.1% CNTs surfaces were higher than ALP
activity on polystyrene surface. Experimental data are expressed as the
ratio between the values of ALP on HA-PMMA or HA-PMMA-0.1%
CNTs versus the polystyrene culture surfaces (mean  S.E.). The enzyme
activity was normalized by viable cell number for each of the 5 inde-
pendent assays conducted from day 2 to day 6 after cell seeding.
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determined through direct contact assays repeatedly approached
lower maximum values of 4.93  105  2.56  104 cells mL1,
for HA/PMMA, and 1.55  105  1.37  104 cells mL1 for
HA/PMMA-CNTs compared to the control polystyrene surface,
which had 1.01  106  3.89  104 cells mL1 (n ¼ 3).
Although slower cell growth rates and lower density values
reflect decreased capability of MG63 cells to proliferate, the
overall cell viability did not change for HA/PMMA or
HA/PMMA-CNTs. These results imply that these HA/PMMA-
CNTs composites are likely not toxic, as both materials have
high cell viability after culturing for longer periods of time
(Fig. 4c). This biocompatibility response is further supported as
HA/PMMA-based implants have been used and considered
patient safe in orthopedic surgery for more than 35 years.39 These
results, obtained with cultured MG63 cells confirm that these
biomaterials supported cell growth from an osteogenic perspec-
tive, which is important with respect to the successful in vivo
responses (Fig. 2).
To further probe the in vitro response to the nanocomposites,
trypan blue dye exclusion independent assays were carried out
between day 1 and day 8 of cell culture (n ¼ 15). These results
revealed that cell viability remained almost unchanged over the
entire experimental period (95  1%, n ¼ 16410 cells, control;
92  1%, n ¼ 3430 cells, HA/PMMA; and 89  2%, n ¼ 3858
cells, HA/PMMA-CNTs). No statistically significant (P ¼ 0.733)
difference was found between the HA/PMMA and HA/PMMA-
CNTs materials when cell viability was assayed directly in multi-
well culture plates using a MTT based assay. The MTT assay
enables the measurement of cell viability by evaluating the
changes in mitochondrial metabolic activity. Changes in the
metabolic activity can result in very significant changes in MTT
reduction results even when the number of viable cells remains
constant.40 The MTT assay also revealed lower viability when
compared with the trypan blue dye exclusion experiments
(Fig. 4c). MTT reduction values from HA/PMMA and HA/
PMMA-CNTs materials at 5 different time points between day 2
and day 6 of culture were 75  4% (HA/PMMA) and 79  10%
(HA/PMMA-CNTs) when compared with corresponding time
point control experiments (i.e., polystyrene wells). Under our
control conditions, a decline of MTT reduction values normal-
ized by viable cell number was observed from day 1 to day 5
(Fig. S2†). The results on cell growth and viability indicate that
HA/PMMA and HA/PMMA-CNTs might anticipate the switch
of MG63 cells to a mature phase, since such cell cultures exhibit
slower growth rates and lower values of MTT reduction without
significant alterations on cell viability when compared to control
cell cultures at the same time point.
Bone remodeling is a continuing process of functional and
structural alterations at cellular level that gives it mature struc-
ture31 thus we wanted to examine temporal activity when inter-
facing our nanocomposites with biological systems. Quantitative
analysis of ALP activity (Fig. 4d) and cellular morphometric
parameters (Fig. 5) were undertaken with respect to effects of our
nanocomposites. The capability of cultured MG63 cells to form
matrix vesicles and osteogenic factor-responsive alkaline phos-
phatase, which are key players in normal bone growth and
development and in its repair and regeneration, has been previ-
ously demonstrated.41–43 Under control conditions, the ALP
activity of MG63 remained almost constant at a level of 12  1This journal is ª The Royal Society of Chemistry 2010IU L1 with 8 independent kinetic assays. Stimulation of the ALP
activity was also observed when using HA/PMMA and HA/
PMMA-CNTs composites in culture (Fig. 4d). We observed a 3-
and 4-fold increase of cellular and secreted ALP, respectively,
with HA/PMMA when compared to a corresponding time-point
control (polystyrene wells); the enzyme activity was normalized
by viable cell number in the wells. This result also agreed with
previous work where a 60% increase of cellular ALP was
observed after exposing MG63 cells for 24 h to PMMA parti-
cles.44 Even more pronounced was evidence showing that the
HA/PMMA-CNTs composites induced a 16- and 22-fold
increase of secreted and cellular ALP activities, respectively. This
finding indicates that this nanocomposite appears to affect
osteoblastic maturation by up-regulating early local cellular
processes in response to cell-material interactions, supporting
our in vivo data (Fig. 2).
From a cell morphology perspective, the profile of MG63 cell
cultures showed significant alterations as expected over time
(Fig. 5). Fig. 5a is a frequency (percentage) histogram of average
cell diameter and circularity observed in day 2 and day 6 after cell
seeding under control conditions. The average diameter distri-
bution plots appeared to consist of four peaks ranging from 5 to
30 mm, reflecting the relative heterogeneity of cell size over time.
Forty-four (44%) of 382 cells were viable with an average
diameter of 20  3 mm at day 2, while the percentage of this cell
population with this diameter (average diameter ¼ 20  4 mm;
n ¼ 2147 cells) decreased to 35% by day 4. This change of the
relative frequency of viable cells with 20 mm diameter was
accompanied by a higher concentration of smaller cells (16% of
382 cells were viable cells with an average diameter of 15  3 mm
at day 2 vs. 35% of 2147 cells were viable cells with an average
diameter of 14  5 mm at day 6), as well as by loss of cell
circularity (70% of 268 cells were viable cells with circularity of
0.89  0.07 at day 2 vs. 37% of 1216 viable cells with a cell
circularity of 0.88  0.09 at day 6). The HA/PMMA-CNTs
shifted both their cell average diameter and circularity distribu-
tions toward a morphometric profile (Fig. 5c) that very much
resembles the profile of 6 day control cultures (Fig. 5a). It is
important to note that the two main peaks remained at the same
position; larger cells at 20  3 mm (day 2) and 20  6 mm (day 6),
and smaller cells at 14  4 mm (day 2) and 13  5 mm (day 6),
respectively.
Cell-substrate interactions have been shown to influence cell
differentiation and maturation, due to alteration of biological
response, including cytoskeleton organization, signal trans-
duction pathways, and gene expression. For example, the
incorporation of nanohydroxyapatite in silicone rubber nano-
composites induced pre-osteoblasts to change from a spherical
morphology with a smooth surface toward a flat morphology,
large in size with a rough cell surface phenotype.45 MG63 cells
also seem to respond to surface morphology and stiffness of the
substrate by changing cell morphology.46,47 In contrast to control
cultures, the relative frequency of large and small cells in cultures
seeded on the disk-shaped HA/PMMA-CNTs composite
remained almost unchanged, with small viable cells representing
45% (day 2) and 43% (day 6), and large viable cells representing
28% (day 2) and 37% (day 6) of the total number of cells (316 and
502 cells on day 2 and day 6, respectively). A shift toward loss of
cell circularity was also observed (29% of 197 cells were viableNanoscale, 2010, 2, 2855–2863 | 2861
Fig. 5 Morphometric characteristics of MG63 cells during culture indicating significant temporal alterations related to the material interface. (a)
Relative frequencies (measured as a percentage) of the average cell diameter and circularity (inset) observed in day 2 (left column) and day 6 (right
column) after cell seeding cultured in polystyrene petri dishes (control). Histogram representations of the effects of (b) HA-PMMA and (c) HA-PMMA-
0.1% CNTs surfaces on the cellular morphometric parameters, cell diameter and circularity (inset). The representative percentage histograms were also
separated based on viable (grey bars) and dead (black bars) cells. The total number of cells analyzed in panels (a), (b) and (c) were 2529, 1205 and 818,
respectively.cells with circularity of 0.88  0.11 at day 2 vs. 32% of 526 cells
that were viable cells with a cell circularity of 0.89  0.10 at day
6). MG63 cell cultures had shown a similar tendency toward
precocity through the observed alterations of cellular morpho-
metric parameters in response to HA/PMMA composite
(Fig. 5b), however the changes in the respective relative2862 | Nanoscale, 2010, 2, 2855–2863frequency histograms were much less prominent than with
HA/PMMA-CNTs (Fig. 5c). Thus, these data appear to confirm
that MG63 cells in contact with HA/PMMA-CNTs have more
differentiated morphologic features. This in vitro finding is in line
with in vivo response (Fig. 2) toward the differentiation of cells
due to our nanocomposites.This journal is ª The Royal Society of Chemistry 2010
Conclusions
Through our studies with this novel MWCNT nanocomposite,
we have found that the use of COOH-functionalized MWCNTs
reinforced with PMMA/HA will provide tremendous advance-
ments in the field of regenerative medicine. Of singular impor-
tance is the mechano-physical advantage this nanocomposite,
which provides for bearing mechanical loads and promoting
osteointegration with surrounding bone tissues. These are
features not observed with previous materials.12,13 Our in vivo and
in vitro studies both showed favorable biocompatibility and
osteointegration for 0.1% MWCNTs/PMMA/HA nano-
composites and furthermore, in our in vivo animal studies, new
bone extended into the bioactive bone cement. These results
confirm that this novel bionanocomposite will be an excellent
candidate for bone integration due to its osteoconductivity and
biocompatibility. We believe that these results will have appli-
cations in a diversity of areas including nanotechnology,
biomaterials, and regenerative medicine.
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